<html><head><meta http-equiv="content-type" content="text/html; charset=us-ascii"></head><body style="overflow-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;"><div class="Apple-Mail-URLShareUserContentTopClass"><br></div><div class="Apple-Mail-URLShareWrapperClass" style="position: relative !important;"><blockquote type="cite" style="border-left-style: none; color: inherit; padding: inherit; margin: inherit;"><b>
Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study<br></b>Debadatta Nayak, Juhi Gupta, Anupriya Chaudhary, Krishna Gopal Singh. Abhijeet Deshmukh. Deblina Das, Abhishek Saha, Deepak Kumar, Ashwini Kumar, Ajay Goenka, S.K.Mishra, Sanjay Gupta, Anil Khurana<br><br>A randomized, placebo-controlled trial of adjunct homeopathy with standard of care for COVID-19 was conducted on 300 patients.<br>Primary outcome on total symptom score measured over 10 days decreased significantly favoring Standard of care + Homeopathy.<br>Recovery was earlier in Standard of care + Homeopathy group by 02 days showing the added benefits of homeopathy.<br>Resolution of fever was 20 h earlier in Standard of care + Homeopathy.<br>Arsenicum album, Bryonia alba and Phosphorus were the most frequently prescribed medicines.<br><br>Disponibile il full-text su richiesta
</blockquote></div></body></html>